The ability to deliver highly compliant biosensors through the toughest membranes of the central and peripheral nervous system is an important challenge in neuroscience and neural engineering.Bioelectronic devices implanted through dura mater and thick epineurium would ideally create minimal compression and acute damage as they reach the neurons of interest. We demonstrate that a novel diamond shuttle can deliver ultra-compliant polymer microelectrodes to intraneural structures with the smallest cross-sectional area and dimpling reported to date. This was demonstrated in vivo through rat dura mater and feline dura and dorsal root epineurium. The dorsal root ganglia are an especially relevant target for organ function and pain research, and unlike dura mater over the brain, its outer membrane cannot be removed surgically. We present a method of creating a unique diamond shuttle, only 11 microns thick with a T-beam vertical support, that pierces dura and epineurium. This T-beam structure reduced the cross-sectional area of the shuttle by 58% relative to an equivalently stiff silicon shuttle. We also discovered that higher frequency oscillation of the shuttle, at 200 Hz, significantly reduced tissue compression regardless of the insertion speed, while slow speeds independently also reduced tissue compression. Finally, we demonstrate the shuttle delivery of and neural recordings from ultra-fine, flexible arrays (5-µm thick, 65-µm wide) with 60 microelectrodes in a 1.2-mm span from different neural targets. This novel microelectrode shuttle has a large design space making it suitable for research in a variety of central and peripheral nervous system targets and animal models.
IntroductionImplantable sensor arrays, especially when deployed in neural mapping studies, are most accurate and insightful when damage and disruption to nervous system circuitry is minimized. Minimizing damage and reactivity has been emphasized by recent global initiatives including the BRAIN Initiative, the NIH SPARC program, the GSK Innovation Challenge, and several DARPA funding programs, which have supported the development of new technology for mapping, monitoring, and/or controlling the nervous system with higher fidelity and longevity. Previous work demonstrated that size of an implant effects the neuron count and several glia markers of reactivity 12 . A precise implant size to tissue damage function is still missing, but evidence suggests that care should be taken to minimize the damage to blood vessels which densely permeate nervous tissue 3,4 . Central nervous system (CNS) neurons, for example, are located within ~15 µm of a capillary vessel 5-7 so damage to the blood-brain barrier is unavoidable.When designing an implantable device, the penetrating structure must be stiff enough to reach the desired target with accuracy and, more challenging, piercing a tough fibrous outer membrane protecting the neurons.These challenges have opposing solutions -make the device as fine as possible for minimal bleeding and cellular disruption, yet ens...